MA55756A - Mirikizumab destiné à être utilisé dans un procédé de traitement de la maladie de crohn - Google Patents

Mirikizumab destiné à être utilisé dans un procédé de traitement de la maladie de crohn

Info

Publication number
MA55756A
MA55756A MA055756A MA55756A MA55756A MA 55756 A MA55756 A MA 55756A MA 055756 A MA055756 A MA 055756A MA 55756 A MA55756 A MA 55756A MA 55756 A MA55756 A MA 55756A
Authority
MA
Morocco
Prior art keywords
mirikizumab
disease
treating crohn
crohn
treating
Prior art date
Application number
MA055756A
Other languages
English (en)
French (fr)
Inventor
Stuart William Friedrich
Paul Frederick Pollack
Jay Lawrence Tuttle
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MA55756A publication Critical patent/MA55756A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244Interleukins [IL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
MA055756A 2019-04-22 2020-04-15 Mirikizumab destiné à être utilisé dans un procédé de traitement de la maladie de crohn MA55756A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962836910P 2019-04-22 2019-04-22

Publications (1)

Publication Number Publication Date
MA55756A true MA55756A (fr) 2022-03-02

Family

ID=70554215

Family Applications (1)

Application Number Title Priority Date Filing Date
MA055756A MA55756A (fr) 2019-04-22 2020-04-15 Mirikizumab destiné à être utilisé dans un procédé de traitement de la maladie de crohn

Country Status (16)

Country Link
US (1) US20220040299A1 (https=)
EP (1) EP3958897A1 (https=)
JP (3) JP7297930B2 (https=)
KR (2) KR102869852B1 (https=)
CN (2) CN113677366A (https=)
AU (2) AU2020263238C1 (https=)
BR (1) BR112021018930A2 (https=)
EA (1) EA202192532A1 (https=)
IL (2) IL286818B2 (https=)
MA (1) MA55756A (https=)
MX (1) MX2021012848A (https=)
SG (1) SG11202110619XA (https=)
TW (2) TW202515610A (https=)
UA (1) UA128657C2 (https=)
WO (1) WO2020219314A1 (https=)
ZA (1) ZA202108094B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202515610A (zh) * 2019-04-22 2025-04-16 美商美國禮來大藥廠 治療克隆氏症(crohn's disease)的方法
KR20220066831A (ko) 2020-11-16 2022-05-24 엔브이에이치코리아(주) 습기경화형 접착제를 이용한 헤드라이닝 제조방법 및 이에 의해 제조되는 헤드라이닝

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR094877A1 (es) 2013-03-08 2015-09-02 Lilly Co Eli Anticuerpos que se unen a il-23
KR20150128859A (ko) 2013-03-15 2015-11-18 암젠 인크 항-il23 항체를 사용하여 크론병을 치료하는 방법
TWI811716B (zh) * 2015-09-18 2023-08-11 德商百靈佳殷格翰國際股份有限公司 治療發炎性疾病之方法
WO2018035330A1 (en) * 2016-08-19 2018-02-22 Janssen Biotech, Inc. Methods of treating crohn's disease with an anti-nkg2d antibody
CA3068673A1 (en) * 2017-07-10 2019-01-17 Rambam Med-Tech Ltd. Assays for assessing neutralizing antibodies levels in subjects treated with a biological drug and uses thereof in personalized medicine
TW202515610A (zh) * 2019-04-22 2025-04-16 美商美國禮來大藥廠 治療克隆氏症(crohn's disease)的方法

Also Published As

Publication number Publication date
EA202192532A1 (ru) 2022-01-21
JP2025148449A (ja) 2025-10-07
KR20210142704A (ko) 2021-11-25
IL324048A (en) 2025-12-01
MX2021012848A (es) 2021-12-10
JP7761614B2 (ja) 2025-10-28
JP2022530397A (ja) 2022-06-29
AU2020263238A1 (en) 2021-11-04
NZ781127A (en) 2025-06-27
CN119700968A (zh) 2025-03-28
ZA202108094B (en) 2025-05-28
IL286818B2 (en) 2026-03-01
AU2020263238B2 (en) 2023-08-17
AU2023265759A1 (en) 2023-12-07
IL286818B1 (en) 2025-11-01
IL286818A (en) 2021-10-31
CA3134587A1 (en) 2020-10-29
SG11202110619XA (en) 2021-11-29
CN113677366A (zh) 2021-11-19
JP7297930B2 (ja) 2023-06-26
TWI850365B (zh) 2024-08-01
JP2023116680A (ja) 2023-08-22
WO2020219314A1 (en) 2020-10-29
KR20250153865A (ko) 2025-10-27
EP3958897A1 (en) 2022-03-02
UA128657C2 (uk) 2024-09-18
KR102869852B1 (ko) 2025-10-14
TW202515610A (zh) 2025-04-16
BR112021018930A2 (pt) 2022-01-18
TW202103734A (zh) 2021-02-01
US20220040299A1 (en) 2022-02-10
AU2020263238C1 (en) 2024-02-22

Similar Documents

Publication Publication Date Title
MA50800A (fr) Nouveaux promédicaments de catécholamine destinés à être utilisés dans le traitement de la maladie de parkinson
EP3975106A4 (en) IMAGE PROCESSING METHOD AND APPARATUS
EP3644996A4 (en) METHOD OF TREATMENT FOR HUNTINGTON'S MORBUS
EP3649646A4 (en) PERSONAL SYSTEM AND METHOD FOR PREVENTING BODY ADAPTATION FOR CHRONIC TREATMENT OF DISEASES
EP3906043A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF FABRY'S DISEASE
EP3599760A4 (en) IMAGE PROCESSING METHOD AND DEVICE
EP4021500A4 (en) METHOD FOR TREATING THYROID EYE DISEASE
EP3572050A4 (en) EXCREMENTAL TREATMENT FOR USE IN COLOSTOMIES
EP3827412A4 (en) IMAGE PROCESSING DEVICE AND METHOD
EP3925203A4 (en) IMAGE PROCESSING DEVICE AND IMAGE PROCESSING METHOD THEREOF
EP3972477A4 (en) SYSTEMS AND METHODS FOR OCT-GUIDED TREATMENT OF A PATIENT
EP3532640A4 (en) METHOD AND SYSTEM FOR PREDICTING THE RESPONSE OF A PATIENT TO ANTIDEPRESSION TREATMENT
EP4122488A4 (en) METHODS AND MEDICATIONS FOR TREATMENT OF ALZHEIMER'S DISEASE
EP3971818A4 (en) IMAGE PROCESSING METHOD AND APPARATUS
EP3790867A4 (en) KDM1A INHIBITORS FOR DISEASE TREATMENT
EP3742958A4 (en) METHOD AND DEVICE FOR TREATMENT OF EYE DISEASES
MA55756A (fr) Mirikizumab destiné à être utilisé dans un procédé de traitement de la maladie de crohn
EP4030680A4 (en) APPLICATION PROCESSING PROCESS AND RELATED PRODUCT
EP4036841A4 (en) IMAGE PROCESSING METHOD AND APPARATUS
EP4068794A4 (en) Image processing method and apparatus
EP3813793A4 (en) COMPOSITION FOR THE TREATMENT OF OCULAR HYPEREMIA AND METHODS FOR TREATMENT OF OCULAR HYPEREMIA THEREFORE
EP4122481A4 (en) METHODS AND MEDICATIONS FOR TREATMENT OF HUNTINGTON'S DISEASE
EP4122490A4 (en) METHODS AND MEDICATIONS FOR TREATMENT OF PARKINSON'S DISEASE
EP3856168A4 (en) COMPOSITION AND USE FOR THE TREATMENT OF PARKINSON'S DISEASE AND RELATED DISEASES
EP3704465A4 (en) DECISION SUPPORT SYSTEM AND METHOD FOR WATER TREATMENT